Shoji Yamane

1.0k citations
36 papers · 822 indexed · h-index 15
Topics
Osteoarthritis Treatment and Mechanisms (6 papers)Immunotherapy and Immune Responses (4 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
Partner nations
JapanUnited StatesSweden

In The Last Decade

Shoji Yamane

36 papers receiving 805 citations

Peers

Shoji Yamane
Comparison fields: 5 of 105
  • Rheumatology 274
  • Molecular Biology 215
  • Oncology 155
  • Immunology 137
  • Pulmonary and Respiratory Medicine 128
Replace Akihiko Okahara with:
Akihiko Okahara Japan
Yoshiharu Amasaki Japan
Claudio Molina Chile
Harukiyo Kawamura Japan
L. Lepescheux Belgium
Hyon J. Kim United States
Qi‐Quan Huang United States
Annelie Möller Germany
Katharine H. Wrighton United States
Jin He China
Shoji Yamane relative to Akihiko Okahara Japan Akihiko Okahara's profile →
Citations per field
00.5×5.3×
Akihiko Okahara · 1×
Citations per year

Countries citing papers authored by Shoji Yamane

Since Specialization
Citations

This map shows the geographic impact of Shoji Yamane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Yamane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Yamane more than expected).

Fields of papers citing papers by Shoji Yamane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoji Yamane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Yamane. The network helps show where Shoji Yamane may publish in the future.

Co-authorship network of co-authors of Shoji Yamane

This figure shows the co-authorship network connecting the top 25 collaborators of Shoji Yamane. A scholar is included among the top collaborators of Shoji Yamane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoji Yamane. Shoji Yamane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 35
3 4
4 12
5 13
6 14
7 13
8 78
9 18
10 6
11 16
12 76
13 73
14 4
15 5
16 152
17 44
18 2
19 9
20 3

About Shoji Yamane

Shoji Yamane is a scholar working on Rheumatology, Immunology and Allergy and Equine, having authored 36 papers that have together received 822 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (6 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Rheumatology (274 citations), Immunology and Allergy (62 citations) and Cancer Research (101 citations). Shoji Yamane has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Ryuji Suzuki, Naoshi Fukui, Yuji Tsuruta, Hitoshi Nakazato, Hisashi Oku, Takahiro Ochi, Yasuko Ikeda, Atsuhiko Hikita, Takuo Juji and Toshihito Mori. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026